Anteotech Ltd has released a press release.
AnteoTech COVID-19 Antigen Test Progress Update
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from AnteoTech
- Preliminary Final Report
- AnteoTech Secures $3.76M Option Underwriting Agreement
- AnteoTech Developing Multiplex Test for COVID-19
- AnteoTech Advances Battery Technology Program
- AnteoTech and Axxin Build Successful Sepsis Multiplex Test
Later from AnteoTech
- AnteoTech Achieve ISO-13485 Certification
- Study Confirms Targeted Sensitivity of COVID-19 Test
- AnteoTech Freeze Design of COVID 19 Test
- $1.19 million R&D Tax Incentive Refund Received
- $3.9M Options Exercise Complete
Follow AnteoTech into a list and get an email when it puts out news.
Follow AnteoTech